Evaluating a CLL susceptibility variant in ITGB2 in families with multiple subtypes of hematological malignancies

Blood. 2017 Jul 6;130(1):86-88. doi: 10.1182/blood-2017-03-774232. Epub 2017 May 10.

Authors

Nicholas B Blackburn^{1

2}, James R Marthick², Annette Banks², Jac C Charlesworth², Katherine A Marsden³, Ray M Lowenthal², John Blangero¹, Joanne L Dickinson²

Affiliations

¹ South Texas Diabetes and Obesity Institute, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX.
² Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia; and.
³ Royal Hobart Hospital, Hobart, TAS, Australia.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Cohort Studies
Genetic Predisposition to Disease
Hematologic Neoplasms / epidemiology
Hematologic Neoplasms / genetics
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / epidemiology
Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
Lymphocyte Function-Associated Antigen-1 / genetics*
Neoplastic Syndromes, Hereditary / epidemiology
Neoplastic Syndromes, Hereditary / genetics
Polymorphism, Single Nucleotide*
Sequence Analysis, DNA
Tasmania / epidemiology

Substances

Lymphocyte Function-Associated Antigen-1